Point of Care Diagnostics Market Share, Size, and Outlook by 2028
Point of Care Diagnostics Market: Size and Share
-
CAGR (2021 - 2028)12.7% -
Market Size 2021
US$ 36 Billion -
Market Size 2028
US$ 82.96 Billion
Market Dynamics
- Increasing Prevalence of Infectious Diseases
- Product Launches and Product Developments
- Increasing Number of CLIA waived POC Tests
- Increasing Use of Home based POC Devices
- High Growth Opportunities in Emerging Markets
- Increasing Number of Conferences and Events
Market Segmentation
- Glucose Monitoring Products
- Infectious Disease Testing Products
- Cardiometabolic Testing Products
- Pregnancy and Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Hematology Testing Products
- Other POC Products
- Prescription-Based Testing and OTC Testing
- Professional Diagnostic Centers
- Home Care
- Research Laboratories
Point of Care Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics
The Point of Care Diagnostics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Point of Care Diagnostics Market are:
- F. Hoffmann-La Roche Ltd
- Abbott
- bioMérieux SA
- Johnson & Johnson Services, Inc.
- Nova Biomedical
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Point of Care Diagnostics Market top key players overview